The stock has finally shown some signs of a longer term reversal.
-Volume impressive
-Golden cross imminent
-Indicators bullish.
Potential long above $66.66
Wedge Breakout
one swing crossed SMA50 and SMA200
Entry 66.3
Stop 63
Target 72
I am not a PRO trader. I trade option to test my trading plan with small cost.
The max Risk of each plan is less than 1% of my account.
If you like this idea, please use SIM/Demo account to try it.
The PEAD projected a Neutral outlook for $GILD after a Negative Under reaction following its earnings release placing the stock in drift A
If you would like to see the Drift for another stock please message us. Also click on the Like Button if this was useful and follow us or join us.
FUNDAMENTALS:
GILD (Gilead Sciences) is that company that found the cure for hepatitis C. The fundamentals are improving again. The industry has not done as well as in others. However, with the recent acquisition of MYR Pharmaceuticals (myr-pharma.com), GILD is currently in phase 3 for the treatment of hepatitis B and D.
TECHNICALS:
Monthly:
wedge...
NASDAQ:GILD
- #GILD exit the bearish channel at the end of December 2021
- Series of higher highs and higher lows since January 2021
- Lower end of the channel coincides with the 50MA
- MACD sloping up
- RSI at good level
Buy price at USD 64.55
1st TP at USD 68.00
2nd TP at USD 72.00
SL at 61.00
Here we see the monthly price trend for GILD if you zoom out further there could be a potential giant bill flag but if we can’t get over that POC I won’t be holding
I know an irregular flat when I see one. It may not rise as much as the shadowed arrow, because the div yield is hefty. I try to open positions in options whose stocks have div yield < 2%, market cap >$15 B and beta > 1. Thats my criteria trichotomy.
This is Gilead Sciences weekly chart. It's been on a very long term down trend. This year's breakout of the recent trend line doesn't signify much as it is halted by the 50 moving average. It is holding at 64-65 support level. Using the Stoch RSI as a cycle guide, it might have an up cycle but a weak one. It might go up to 66-68 level before heading down. If it...
Gilead (GILD) (February 4th 2021 through March 17th 2021)
Low: $63.74 - $64.15
High: $75 - $82 - $87
2020 Q4 reports are announced after market close today.
My expectations and speculations are as follows:
Year-ahead guidance to be positive.
EPS might not outperform the $2.04 analyst expectations.
I believe trading will still close positive tomorrow from...
